From July 14, 2023 to September 30, 2023, the company has repurchased 16,019,740 shares, representing 0.82% for CNY 73.94 million. With this, the company has completed the repurchase of 16,019,740 shares, representing 0.82% for CNY 73.94 million under the buyback announced on July 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.58 CNY | 0.00% | -3.50% | -19.37% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.37% | 943M | |
+39.90% | 6.14B | |
-22.06% | 4.15B | |
+10.94% | 3.45B | |
-18.63% | 2.86B | |
-9.17% | 2.34B | |
+44.13% | 1.92B | |
-5.16% | 1.56B | |
+52.16% | 1.57B | |
-16.04% | 1.48B |
- Stock Market
- Equities
- 002390 Stock
- News Guizhou Xinbang Pharmaceutical Co., Ltd.
- Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.